Mainz Biomed B.V.
NASDAQ:MYNZ
0.2541 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.215 | 0.182 | 0.249 | 0.25 | 0.193 | 0.097 | 0.139 | 0.101 | 0.16 | 0.144 | 0.417 | 0.144 | 0.123 | 0.123 | 0.123 | 0.123 | 0.07 | 0.07 | 0.07 | 0.07 |
| Cost of Revenue
| 0.08 | 0.094 | 0.1 | 0.111 | 0.157 | 0.078 | 0.065 | 0.054 | 0.335 | 0.1 | 0.065 | 0.1 | 0.093 | 0.093 | 0.093 | 0.093 | 0.086 | 0.086 | 0.086 | 0.086 |
| Gross Profit
| 0.135 | 0.087 | 0.149 | 0.139 | 0.036 | 0.019 | 0.074 | 0.046 | -0.175 | 0.044 | 0.353 | 0.044 | 0.031 | 0.031 | 0.031 | 0.031 | -0.015 | -0.015 | -0.015 | -0.015 |
| Gross Profit Ratio
| 0.627 | 0.48 | 0.598 | 0.556 | 0.188 | 0.192 | 0.534 | 0.462 | -1.093 | 0.308 | 0.845 | 0.308 | 0.249 | 0.249 | 0.249 | 0.249 | -0.218 | -0.218 | -0.218 | -0.218 |
| Reseach & Development Expenses
| 1.999 | 1.855 | 3.479 | 2.625 | 1.958 | 0.909 | 0.348 | 0.564 | 0.261 | 0.117 | 0.206 | 0.117 | 0.078 | 0.078 | 0.078 | 0.078 | 0.063 | 0.063 | 0.063 | 0.063 |
| General & Administrative Expenses
| 3.531 | 2.751 | 2.797 | 2.408 | 4.281 | 3.979 | 5.23 | 4.238 | 8.227 | 2.353 | 0.251 | 2.353 | 0.115 | 0.115 | 0.115 | 0.115 | 0.143 | 0.143 | 0.143 | 0.143 |
| Selling & Marketing Expenses
| 1.248 | 1.122 | 1.8 | 1.562 | 2.031 | 0.606 | 1.441 | 0.842 | 0.807 | 0.239 | 0.15 | 0.239 | 0.028 | 0.028 | 0.028 | 0.028 | 0.045 | 0.045 | 0.045 | 0.045 |
| SG&A
| 4.779 | 3.873 | 4.596 | 3.97 | 6.312 | 4.585 | 6.672 | 5.08 | 9.035 | 2.592 | 0.241 | 0.04 | 0.142 | 0.142 | 0.142 | 0.142 | 0.188 | 0.188 | 0.188 | 0.188 |
| Other Expenses
| 2.378 | -0.659 | -0.326 | 0.031 | 0.457 | -0.121 | 0.056 | -0.032 | 0.011 | 0.011 | 0.011 | 0.011 | 0.008 | 0.008 | 0.008 | 0.008 | 0.004 | 0.004 | 0.004 | 0.004 |
| Operating Expenses
| 6.935 | 5.728 | 8.075 | 6.626 | 8.327 | 5.494 | 6.953 | 5.678 | 11.083 | 2.72 | 0.241 | 0.04 | 0.228 | 0.228 | 0.228 | 0.228 | 0.254 | 0.254 | 0.254 | 0.254 |
| Operating Income
| -6.59 | -5.641 | -7.926 | -6.488 | -8.454 | -5.476 | -6.948 | -5.632 | -9.47 | -2.345 | -0.241 | -0.04 | -0.089 | -0.089 | -0.089 | -0.089 | -0.188 | -0.188 | -0.188 | -0.188 |
| Operating Income Ratio
| -30.687 | -31.049 | -31.839 | -25.939 | -43.741 | -56.571 | -49.899 | -55.999 | -59.174 | -16.245 | -0.577 | -0.277 | -0.722 | -0.722 | -0.722 | -0.722 | -2.671 | -2.671 | -2.671 | -2.671 |
| Total Other Income Expenses Net
| 2.426 | -0.659 | -0.326 | -0.073 | 0.391 | -0.121 | 0.056 | -0.032 | -1.958 | -0.579 | -0 | -0 | -0.058 | -0.058 | -0.058 | -0.058 | -0.051 | -0.051 | -0.051 | -0.051 |
| Income Before Tax
| -5.183 | -6.3 | -8.252 | -6.561 | -8.189 | -5.596 | -6.939 | -5.664 | -11.428 | -2.924 | -0.241 | -0.04 | -0.147 | -0.147 | -0.147 | -0.147 | -0.239 | -0.239 | -0.239 | -0.239 |
| Income Before Tax Ratio
| -24.135 | -34.677 | -33.147 | -26.233 | -42.367 | -57.818 | -49.833 | -56.319 | -71.411 | -20.257 | -0.577 | -0.277 | -1.189 | -1.189 | -1.189 | -1.189 | -3.401 | -3.401 | -3.401 | -3.401 |
| Income Tax Expense
| 1.968 | 0 | 0.049 | 0.073 | -0.085 | 0 | 0.139 | 0 | 0.085 | -0.494 | -0.494 | -0.494 | 0.01 | 0.01 | 0.01 | 0.01 | -0.001 | -0.001 | -0.001 | -0.001 |
| Net Income
| -5.183 | -6.3 | -8.252 | -6.634 | -8.189 | -5.596 | -6.939 | -5.664 | -11.428 | -2.923 | -0.241 | -0.04 | -0.147 | -0.147 | -0.147 | -0.147 | -0.239 | -0.239 | -0.239 | -0.239 |
| Net Income Ratio
| -24.135 | -34.677 | -33.147 | -26.526 | -42.367 | -57.818 | -49.833 | -56.319 | -71.411 | -20.248 | -0.577 | -0.277 | -1.189 | -1.189 | -1.189 | -1.189 | -3.401 | -3.401 | -3.401 | -3.401 |
| EPS
| -0.24 | -0.39 | -0.55 | -0.45 | -0.58 | -0.39 | -0.5 | -0.42 | -1.3 | -0.41 | -0.02 | -0.003 | -0.013 | -0.013 | -0.013 | -0.013 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted
| -0.24 | -0.39 | -0.55 | -0.45 | -0.58 | -0.39 | -0.49 | -0.42 | -1.3 | -0.41 | -0.02 | -0.003 | -0.013 | -0.013 | -0.013 | -0.013 | -0.02 | -0.02 | -0.02 | -0.02 |
| EBITDA
| -5.437 | -5.437 | -7.755 | -6.2 | -7.969 | -5.403 | -6.827 | -5.597 | -9.498 | -2.83 | -0.241 | -0.04 | -0.073 | -0.073 | -0.073 | -0.073 | -0.184 | -0.184 | -0.184 | -0.184 |
| EBITDA Ratio
| -25.317 | -29.928 | -31.152 | -24.791 | -41.232 | -55.818 | -49.034 | -55.653 | -59.35 | -19.609 | -0.577 | -0.277 | -0.592 | -0.592 | -0.592 | -0.592 | -2.61 | -2.61 | -2.61 | -2.61 |